Greenwich LifeSciences
GLSI
#7975
Rank
โ‚น15.60 B
Marketcap
โ‚น1,187
Share price
-1.19%
Change (1 day)
61.45%
Change (1 year)

P/E ratio for Greenwich LifeSciences (GLSI)

P/E ratio as of September 2024 (TTM): -19.9

According to Greenwich LifeSciences's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -19.9296. At the end of 2022 the company had a P/E ratio of -24.9.

P/E ratio history for Greenwich LifeSciences from 2020 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-24.9-63.13%
2021-67.6-72.19%
2020-243

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
-8.39-57.89% Jersey
-1.85-90.72%๐Ÿ‡บ๐Ÿ‡ธ USA
-0.2261-98.87%๐Ÿ‡บ๐Ÿ‡ธ USA
-2.69-86.48%๐Ÿ‡ฌ๐Ÿ‡ง UK

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.